| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.068 | 0.1 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.067 | 0.2 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.051 | 0.3 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.049 | 0.3 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.038 | 0.4 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.038 | 0.4 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.024 | 0.6 |